1Pintar T, Collard CD. The systemic inflammatory response to cardiopulmonary bypass [ J ]. Anesthesiol Clin North America, 2003,21 : 453 -464.
2Rothenburger M, Soeparwata R, Deng MC, et al. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and antiendotoxin core antibodies[J]. Shock,2001,16(Suppl 1 ) : 44 - 50.
3Schneider M, Valentine S, Hegde RM, et al. The effect of different bypass flow rates and low - dose dopamine on gut mucosal perfusion and outcome in cardiac surgical patients[J]. Anaesth Intensive Care, 1999,27 :139.
4Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to lim it functional neutrophil activity during cardiac surgery[J]. Inflamma Res,2002, 51:363-368.
5Olivencia Yurvati AH, Ferrara CA, Tiemey N, et al. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post - cardiopulmonary bypass [ J ]. Perfusion, 2003,18(suppl 1):23-31.
7Thomas MH, Heinz ML, Hugo VA, et al. Milrinone modulates endotoxemia, systemin inflammation, and subsequent acutephase response after cardiopulmonary bypass[J]. Anesthesiology, 1999, 90:72-79.
8Brouicki RA, Backer CL, Baden HP, et al. Dexamethosone reduce the inflammatory response to cardiopulmonary bypass in children[ J ]. Ann Thorac Surg, 2000, 69(5):1490-1495.
9Bourbon A, Vionnet M, Leprince P, et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass - induced systemic inflammatory response [J]. Eur J Cardiothoracic Surg, 2004 , 26 : 932 -938.
10Hayashinda N, Tomoeda H, Oda T, et al. Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass[J]. Ann Thorac Surg 1999, 68 : 1661 - 1667.
二级参考文献3
1Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion, 1991,6:41-50.
2Wang MJ, Chiu IS, Hsu CM, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg,1996,61:651-656.
